The FDA’s emergency move against screwworm is less about paperwork and more about racing a parasite that can chew through animals fast.
Story Snapshot
- The Food and Drug Administration issued an emergency use authorization for nitenpyram to treat New World screwworm in eligible dogs and cats.
- The authorization covers dogs, puppies, cats, and kittens that weigh at least two pounds and are at least four weeks old.
- The FDA says the drug may be effective and that its benefits outweigh its known and potential risks.
- The treatment is fast-acting, but it does not prevent reinfestation and may still require a veterinarian to remove larvae.
What the FDA Actually Did
The Food and Drug Administration issued an Emergency Use Authorization for generic nitenpyram tablets to treat New World screwworm infestations in certain dogs and cats.[1]
That matters because this was not a broad approval for every pet problem. It was a narrow, emergency-only move for a specific parasite and a specific group of animals.[2]
The FDA issued an emergency use authorization to treat dogs and cats for New World screwworm after at least seven cases were reported. The outbreak, to this point, has infected six livestock and one pet in Texas and New Mexico.
More: https://t.co/DD0F0i60Zp pic.twitter.com/NkEQ0skoZq
— NewsNation (@NewsNation) June 12, 2026
The agency said the treatment applies to dogs, puppies, cats, and kittens that weigh at least two pounds and are at least four weeks old.[1] It also said this is the first generic animal drug authorized for use against the New World screwworm.[1] That gives the decision a strong sense of urgency. It also shows how tightly the FDA drew the boundaries.
Why Regulators Moved Fast
The FDA said its review found it reasonable to believe that nitenpyram may be effective against New World screwworm in certain pets.[1] The agency also concluded that the known and potential benefits outweigh the known and potential risks.[1]
That is the core of the emergency case. When a threat is active, regulators often accept less complete evidence than they would for a full approval.[2]
New World screwworm is not a normal skin issue. It is a parasitic infestation that can damage tissue and become severe if not treated.[2]
The emergency declaration from the Department of Health and Human Services allows the FDA to use a faster path for animal drugs intended to address the threat.[2] That is the kind of tool regulators reserve for situations where delay itself carries risk.
What Pet Owners Need to Understand
Nitenpyram works quickly, and the FDA says it can kill most larvae within hours after the first dose.[1] A second dose is recommended six hours later.[1]
That speed is the appeal. But fast does not mean complete. The FDA also says the drug does not prevent future infestation or protect against reinfestation.[1]
🐾 THE DAILY BARK: NATIONAL EDITION (6/12) 🐾Your daily dose of canine news, health, and heart.Powered by https://t.co/BWbYHM1oZs.▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬▬.🌐 NATIONAL DOG NEWS.
■ 1️⃣ FDA AUTHORIZES FIRST GENERIC EMERGENCY SCREWWORM TREATMENT: Escalating…— BarkleyAndPaws (@BarkleyAndPaws) June 12, 2026
The treatment is also not a do-it-yourself fix in every case. After the drug is given, a veterinary professional may still need to remove any remaining live or dead larvae.[1]
That detail matters because it keeps the focus on care, not shortcuts. The drug is a tool, not a guarantee. For pet owners, the real message is simple: act fast, follow the directions, and do not assume the problem is over just because the medicine was given.
Why This Story Is Bigger Than One Drug
This decision fits a familiar pattern in emergency regulation. Authorities see a live threat, find limited but supportive evidence, and open a temporary lane for treatment.[2]
That can unsettle people who want perfect certainty. It can also save time when an animal faces a serious parasite and no standard approval is yet available. The tension is not new. It is the price of acting before a threat spreads further.
For readers who care about common sense, the most important point is this: the FDA did not claim nitenpyram is magic, nor did it claim that emergency use equals full approval.[1][2]
It claimed the evidence was sufficient for a limited response in eligible pets, while the broader threat remains active. That is a restrained decision, and restraint is often the most honest response to a fast-moving animal health emergency.
Sources:
[1] Web – FDA clears emergency use of drug to fight screwworm infections in pets
[2] Web – FDA Issues Emergency Use Authorization for Generic Over-the …
